PDI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Perit Dial Int 24(6): 554-561 2004
© 2004 International Society for Peritoneal Dialysis
This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Esch, S
Right arrow Articles by Krediet, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Esch, S
Right arrow Articles by Krediet, R.
Peritoneal Dialysis International, Vol 24, Issue 6, 554-561
Copyright © 2004 by International Society for Peritoneal Dialysis

Articles

Determinants of peritoneal solute transport rates in newly started nondiabetic peritoneal dialysis patients

S van Esch, MM Zweers, MA Jansen, DR de Waart, JG van Manen, and RT Krediet

Department of Nephrology, Academic Medical Center, University of Amsterdam, The Netherlands.

OBJECTIVE: An overrepresentation of a fast peritoneal transport status in new peritoneal dialysis (PD) patients with extensive comorbidity has been reported in some studies. High mass transfer area coefficients (MTACs) of low MW solutes suggest the presence of a large effective peritoneal surface area. The mechanism is unknown. It might include comorbidity, chronic inflammation, or an effect of mesothelial cell mass on peritoneal transport by the production of vasoactive substances. To investigate their relative importance in early PD, peritoneal permeability characteristics in incident PD patients were analyzed for relationships with comorbidity, serum concentrations of inflammatory markers, and products of the mesothelial cells that can be detected in dialysate. DESIGN: A cross-sectional study. SETTING: A university hospital. METHODS: 46 patients who fulfilled the following inclusion criteria were analyzed: a standard peritoneal permeability analysis (SPA) within 6 months after the start of PD, no peritonitis prior to the SPA, older than 18 years, and without diabetes mellitus as a primary renal disease. The patients were divided into tertiles based on the MTAC creatinine: slow, medium, and fast transport groups. The Davies comorbidity score was used to assess comorbidity. Serum and dialysate samples obtained during the SPA were used to determine hyaluronan, interleukin (IL)-6, vascular endothelial growth factor (VEGF), and cancer antigen 125 (CA125). The dialysate concentrations of these substances were expressed as their dialysate appearance rates. RESULTS: No significant differences were present in the three transport groups for comorbidity, serum concentrations of inflammatory markers, or serum VEGF. Interleukin-6 and VEGF concentration attributed to local VEGF production were not different between the tertiles. Levels of VEGF were higher in the medium transport group compared to the slow transport group (p = 0.02); CA125 was higher in the fast transport group compared to the medium transport group (p= 0.01). When analyzed as continuous variables, MTAC creatinine was related to VEGF (r= 0.33, p < 0.05) and CA125 (r= 0.41, p = 0.03). In linear regression analysis, VEGF influenced the association between CA125 and MTAC creatinine; IL-6 weakened this association only marginally. CONCLUSION: A fast peritoneal transport status in incident nondiabetic PD patients was not related to comorbidity. The relationships found between VEGF, CA125, and MTAC creatinine may suggest a role of VEGF in the regulation of the vascular peritoneal surface area, possibly already before structural abnormalities have developed. Our analyses are consistent with the hypothesis that mesothelial cell mass is an important determinant of the peritoneal transport status in incident nondiabetic PD patients without previous peritonitis. Of the many potential mediators produced by mesothelial cells, VEGF was more important than the inflammation marker IL-6.




This article has been cited by other articles:


Home page
 NDT PlusHome page
D. G. Struijk
Monitoring of the peritoneal membrane
NDT Plus, October 1, 2008; 1(suppl_4): iv29 - iv35.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
A. M. Coester, M. M. Zweers, D. R. de Waart, and R. T. Krediet
The relationship between effluent potassium due to cellular release, free water transport and CA125 in peritoneal dialysis patients
NDT Plus, October 1, 2008; 1(suppl_4): iv41 - iv45.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
K.-H. Oh, J.-Y. Moon, J. Oh, S. G. Kim, Y.-H. Hwang, S. Kim, J. S. Lee, and C. Ahn
Baseline peritoneal solute transport rate is not associated with markers of systemic inflammation or comorbidity in incident Korean peritoneal dialysis patients
Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2356 - 2364.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
A. S. Rodrigues, M. Almeida, I. Fonseca, M. Martins, M. J. Carvalho, F. Silva, C. Correia, M. J. Santos, and A. Cabrita
Peritoneal fast transport in incident peritoneal dialysis patients is not consistently associated with systemic inflammation
Nephrol. Dial. Transplant., March 1, 2006; 21(3): 763 - 769.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Multimed Inc. logo
Copyright © 2004 by Multimed Inc.